162 related articles for article (PubMed ID: 23161117)
1. Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer.
Hata M; Taguchi T; Koike I; Nishimura G; Takahashi M; Komatsu M; Sano D; Odagiri K; Minagawa Y; Inoue T
Strahlenther Onkol; 2013 Jan; 189(1):26-32. PubMed ID: 23161117
[TBL] [Abstract][Full Text] [Related]
2. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.
Lefebvre JL; Rolland F; Tesselaar M; Bardet E; Leemans CR; Geoffrois L; Hupperets P; Barzan L; de Raucourt D; Chevalier D; Licitra L; Lunghi F; Stupp R; Lacombe D; Bogaerts J; Horiot JC; Bernier J; Vermorken JB; ;
J Natl Cancer Inst; 2009 Feb; 101(3):142-52. PubMed ID: 19176454
[TBL] [Abstract][Full Text] [Related]
3. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
[TBL] [Abstract][Full Text] [Related]
4. Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.
Semrau S; Waldfahrer F; Lell M; Linke R; Klautke G; Kuwert T; Uder M; Iro H; Fietkau R
Strahlenther Onkol; 2011 Jan; 187(1):15-22. PubMed ID: 21234526
[TBL] [Abstract][Full Text] [Related]
5. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
6. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
7. Cancer of the larynx in females.
Sas-Korczynska B; Korzeniowski S; Skolyszewski J
Cancer Radiother; 2003 Dec; 7(6):380-5. PubMed ID: 14725911
[TBL] [Abstract][Full Text] [Related]
8. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen: long-term tumor control and complications.
Haffty BG; Hurley RA; Peters LG
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):13-20. PubMed ID: 10477001
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy after partial laryngectomy: an analysis of 36 cases and a proposal to optimize radiotherapy.
Garibaldi E; Bresciani S; Airaldi C; Panaia R; Ferrara T; Delmastro E; Baiotto B; Gabriele P
Tumori; 2009; 95(2):198-206. PubMed ID: 19579866
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.
Shimm DS; Coulthard SW
Am J Clin Oncol; 1989 Feb; 12(1):17-23. PubMed ID: 2912019
[TBL] [Abstract][Full Text] [Related]
12. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
Dyckhoff G; Plinkert PK; Ramroth H
BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
[TBL] [Abstract][Full Text] [Related]
13. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
[TBL] [Abstract][Full Text] [Related]
14. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT
Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498
[TBL] [Abstract][Full Text] [Related]
15. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
[TBL] [Abstract][Full Text] [Related]
16. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy.
Spriano G; Antognoni P; Sanguineti G; Sormani M; Richetti A; Ameli F; Piantanida R; Luraghi R; Magli A; Corvo R; Tordiglione M; Vitale V
Am J Otolaryngol; 2000; 21(1):14-21. PubMed ID: 10668672
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer.
Eisbruch A; Thornton AF; Urba S; Esclamado RM; Carroll WR; Bradford CR; Hazuka MB; Littles FJ; Strawderman M; Wolf GT
J Clin Oncol; 1996 Aug; 14(8):2322-30. PubMed ID: 8708724
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of laryngeal carcinoma with subglottis involvement.
Chiesa F; Tradati N; Calabrese L; Zurrida S; DePaoli F; Costa L; Molinari R
Oncol Rep; 2001; 8(1):137-40. PubMed ID: 11115585
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
[TBL] [Abstract][Full Text] [Related]
20. Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.
Knab BR; Salama JK; Solanki A; Stenson KM; Cohen EE; Witt ME; Haraf DJ; Vokes EE
Ann Oncol; 2008 Sep; 19(9):1650-4. PubMed ID: 18467314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
